These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 4674398

  • 1. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG, Caldwell JG.
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [Abstract] [Full Text] [Related]

  • 2. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A, Nuti R, Vattimo A, Galli M, Turchetti V, Franci B, Martorelli T, Righi G.
    Minerva Med; 1983 Apr 28; 74(18):993-1010. PubMed ID: 6087215
    [Abstract] [Full Text] [Related]

  • 3. Porcine calcitonin in the treatment of Paget's disease of bone: experience with 32 patients.
    Plehwe WE, Hudson J, Clifton-Bligh P, Posen S.
    Med J Aust; 1977 Apr 16; 1(16):577-81. PubMed ID: 559908
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F, Ringe JD, Kruse HP.
    Dtsch Med Wochenschr; 1981 Nov 27; 106(48):1620-3. PubMed ID: 7308002
    [Abstract] [Full Text] [Related]

  • 6. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May 27; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 7. [A test for acute hypocalcemia using swine and salmon calcitonin].
    Fournié A, Valverde C, Tap G, Bazerque JJ, Ayrolles C.
    Rev Rhum Mal Osteoartic; 1977 Feb 27; 44(2):91-8. PubMed ID: 847364
    [Abstract] [Full Text] [Related]

  • 8. [Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease].
    Grauer A, Frank-Raue K, Schroth J, Raue F, Ziegler R.
    Dtsch Med Wochenschr; 1994 Apr 08; 119(14):507-10. PubMed ID: 8156882
    [Abstract] [Full Text] [Related]

  • 9. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978 Apr 08; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 08; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 11. [The hypocalcemia test, using human and salmon synthetic calcitonins. Paradoxical hypercalcemic responses. Responses in patients with Paget's disease treated with EHDP].
    Alexandre C, Chapuy MC, Meunier P.
    Rev Rhum Mal Osteoartic; 1979 May 08; 46(5):335-42. PubMed ID: 116360
    [Abstract] [Full Text] [Related]

  • 12. An evaluation of antibodies and clinical resistance to salmon calcitonin.
    Singer FR, Aldred JP, Neer RM, Krane SM, Potts JT, Bloch KJ.
    J Clin Invest; 1972 Sep 08; 51(9):2331-8. PubMed ID: 4674133
    [Abstract] [Full Text] [Related]

  • 13. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.
    DeRose J, Singer FR, Avramides A, Flores A, Dziadiw R, Baker RK, Wallach S.
    Am J Med; 1974 Jun 08; 56(6):858-66. PubMed ID: 4857531
    [No Abstract] [Full Text] [Related]

  • 14. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A.
    Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428
    [Abstract] [Full Text] [Related]

  • 15. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD, Collins-Yudiskas B.
    Arch Intern Med; 1987 Jul 23; 147(7):1305-8. PubMed ID: 3111398
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses.
    Kanis JA, Fitzpatrick K, Strong JA.
    Q J Med; 1975 Jul 23; 44(175):399-413. PubMed ID: 1101286
    [Abstract] [Full Text] [Related]

  • 17. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of the painful Paget's disease of the pelvis with salmon calcitonin in ambulant care. Studies in 2 cases during 26 and 19 months respectively].
    Staehelin A.
    Schweiz Med Wochenschr; 1975 Dec 13; 105(50):1704-5. PubMed ID: 1215961
    [Abstract] [Full Text] [Related]

  • 19. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP, Daumont A, Bouvier M, Lejeune E.
    Nouv Presse Med; 1978 Nov 25; 7(41):3753-6. PubMed ID: 733525
    [Abstract] [Full Text] [Related]

  • 20. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F, Muff R, Dotti-Sigrist S, Dambacher MA, Fischer JA.
    J Clin Endocrinol Metab; 1988 Sep 25; 67(3):541-5. PubMed ID: 3410939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.